Therapeutic Interventions Targeting Innate Immune Receptors: A Balancing Act
- 6 December 2021
- journal article
- review article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 122 (3) , 3414-3458
Abstract
The innate immune system is an organism’s first line of defense against an onslaught of internal and external threats. The downstream adaptive immune system has been a popular target for therapeutic intervention, while there is a relative paucity of therapeutics targeting the innate immune system. However, the innate immune system plays a critical role in many human diseases, such as microbial infection, cancer, and autoimmunity, highlighting the need for ongoing therapeutic research. In this review, we discuss the major innate immune pathways and detail the molecular strategies underpinning successful therapeutics targeting each pathway as well as previous and ongoing efforts. We will also discuss any recent discoveries that could inform the development of novel therapeutic strategies. As our understanding of the innate immune system continues to develop, we envision that therapies harnessing the power of the innate immune system will become the mainstay of treatment for a wide variety of human diseases.Keywords
Funding Information
- U.S. Department of War (W81XWH-18-1-0041)
- National Institutes of Health (1DP2CA228044, 1F30CA250145)
This publication has 545 references indexed in Scilit:
- The Innate Immune DNA Sensor cGAS Produces a Noncanonical Cyclic Dinucleotide that Activates Human STINGCell Reports, 2013
- Structure of Human cGAS Reveals a Conserved Family of Second-Messenger Enzymes in Innate ImmunityCell Reports, 2013
- Structural Insights into RNA Recognition by RIG-ICell, 2011
- Activation of STAT6 by STING Is Critical for Antiviral Innate ImmunityCell, 2011
- MAVS Forms Functional Prion-like Aggregates to Activate and Propagate Antiviral Innate Immune ResponseCell, 2011
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin LymphomaCell, 2010
- Induction of neuronal apoptosis inhibitory protein expression in response to androgen deprivation in prostate cancerCancer Letters, 2010
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem CellsCell, 2009
- Diverse functions of RNase L and implications in pathologyBiochimie, 2007
- The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamilyEuropean Journal of Immunology, 2003